SE9803609D0 - New peptides and cDNA as well as use thereof - Google Patents

New peptides and cDNA as well as use thereof

Info

Publication number
SE9803609D0
SE9803609D0 SE9803609A SE9803609A SE9803609D0 SE 9803609 D0 SE9803609 D0 SE 9803609D0 SE 9803609 A SE9803609 A SE 9803609A SE 9803609 A SE9803609 A SE 9803609A SE 9803609 D0 SE9803609 D0 SE 9803609D0
Authority
SE
Sweden
Prior art keywords
well
peptides
cdna
new peptides
hyperlipidemia
Prior art date
Application number
SE9803609A
Other languages
Swedish (sv)
Inventor
Bjoern Carlsson
Lena Carlsson
Magnus Johnson
Original Assignee
Bjoern Carlsson
Lena Carlsson
Magnus Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Carlsson, Lena Carlsson, Magnus Johnson filed Critical Bjoern Carlsson
Priority to SE9803609A priority Critical patent/SE9803609D0/en
Publication of SE9803609D0 publication Critical patent/SE9803609D0/en
Priority to PCT/SE1999/001902 priority patent/WO2000023475A1/en
Priority to AU14291/00A priority patent/AU1429100A/en
Priority to EP99970667A priority patent/EP1131353A1/en

Links

Abstract

The invention relates to new peptides corresponding substantially to the intracellular C-terminal domain of a mammalian HDL-receptor, or mimetics or functionally equivalent homologues, analogues or fragments thereof, and also to cDNA encoding such peptides. Said peptides are suitable for use in medicinal products for treatment of hyperlipidemia by modulation of cholesterol, bile acid, and/or lipid metabolism of a patient, as well as for identification of drug targets for treatment of hyperlipidemia.
SE9803609A 1998-10-22 1998-10-22 New peptides and cDNA as well as use thereof SE9803609D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9803609A SE9803609D0 (en) 1998-10-22 1998-10-22 New peptides and cDNA as well as use thereof
PCT/SE1999/001902 WO2000023475A1 (en) 1998-10-22 1999-10-22 Intracellular c-terminal hdl-receptor domain
AU14291/00A AU1429100A (en) 1998-10-22 1999-10-22 Intracellular c-terminal hdl-receptor domain
EP99970667A EP1131353A1 (en) 1998-10-22 1999-10-22 Intracellular c-terminal hdl-receptor domain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803609A SE9803609D0 (en) 1998-10-22 1998-10-22 New peptides and cDNA as well as use thereof

Publications (1)

Publication Number Publication Date
SE9803609D0 true SE9803609D0 (en) 1998-10-22

Family

ID=20413040

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803609A SE9803609D0 (en) 1998-10-22 1998-10-22 New peptides and cDNA as well as use thereof

Country Status (4)

Country Link
EP (1) EP1131353A1 (en)
AU (1) AU1429100A (en)
SE (1) SE9803609D0 (en)
WO (1) WO2000023475A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429289B1 (en) * 1994-06-23 2002-08-06 Massachusetts Institute Of Technology Class BI and CI scavenger receptors
US5925333A (en) * 1995-11-15 1999-07-20 Massachusetts Institute Of Technology Methods for modulation of lipid uptake

Also Published As

Publication number Publication date
AU1429100A (en) 2000-05-08
WO2000023475A1 (en) 2000-04-27
EP1131353A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
ATE467425T1 (en) TARGETED DELIVERY OF PHARMACEUTICAL AGENTS TO INJURED TISSUES
HK1043543A1 (en) Modified factor VIII.
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
ATE374625T1 (en) DENDRIMERS FOR USE IN TARGETED ADMINISTRATION
AR024074A1 (en) ABETA FRAGMENT JOINED WITH A BEARING PEPTIDE TO PREVENT OR TREAT DISEASES ASSOCIATED WITH ABETA AMILOID DEPOSITS, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND ITS USE IN THE PREPARATION OF MEDICINES.
BR9710452A (en) Anïïlogos of exendin processes for its preparation and medicines containing the same
BG104075A (en) Combined treatment including atorvastatin and an antihypertonic form
GB2340121B (en) Delivery system
DE60225118D1 (en) COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES
IL151371A (en) Modified porcine factor viii and pharmaceutical compositions containing the same
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
BRPI0409914A (en) substituted carboxylic acids
PT749317E (en) THERAPEUTIC APPLICATIONS OF DIMERIC PRODUCTS OF PERMEABILITY INDUCED BACTERICID PROTEINS
BR9810121A (en) Use of native or esterified petroselinic acid
SE0002202D0 (en) New peptides
ATE297750T1 (en) USE OF HSP70 PROTEIN
BR0111506A (en) Macromolecular drug complexes and compositions containing same
EP1071443A4 (en) Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
DE59906362D1 (en) USE OF LIPOPEPTIDES OR LIPOPROTEINS FOR WIND TREATMENT
HUP0001458A2 (en) Specific pancreatic lipase inhibitor peptides, pharmaceutical compositions and diagnostical reagents comprising thereof and their applications
SE9803609D0 (en) New peptides and cDNA as well as use thereof
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
DK1165102T3 (en) Matrix protein preparations for grafting in non-mineralized tissue
IT1294967B1 (en) IMMUNOGENIC COMPOSITION FROM TLP
ATE278014T1 (en) TARGET FOR THE TREATMENT OF ATHEROSCLEROSIS, OBESITY AND DIABETIS TYPE II